Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat malaria in developing countriesBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7534.151 (Published 19 January 2006) Cite this as: BMJ 2006;332:151
A mix-up during submission led to the wrong version of table 3 being included in the full version of this paper (see bmj.com) by Chantal M Morel and colleagues (BMJ 2005;331:1299-302, 3 Dec). The R0 value for case management with chloroquine should be 0.35 (rather than 0.3). The adherence for artemisinin based combination treatment should be 35% (not 40%), and neither that nor the adherence for non-artemisinin based treatment needs a footnote. Values for probability of success when patients were not fully compliant should be 35% for non-artemisinin based treatment and 0% for intermittent presumptive treatment during pregnancy (rather than 35% and 10% respectively, as given). These revised values also apply to table B on bmj.com.